Issue

Vol. 37 No. 10 (2025): Vol 37 Issue 10, 2025

Copyright (c) 2025 Jayashree P, Meenambiga SS, Hanishka P

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

In silico Analysis and Antioxidant Activity of Flavonoids from Tinospora cordifolia Targeting α-Synuclein of Parkinson’s Disease

https://doi.org/10.14233/ajchem.2025.34458
Jayashree Pandurangan
Department of Bioengineering, School of Engineering, Vels Institute of Science Technology and Advanced Studies, Chennai-600117, India
https://orcid.org/0009-0008-6957-9256
Hanishka Pothiraj
Department of Bioengineering, School of Engineering, Vels Institute of Science Technology and Advanced Studies, Chennai-600117, India
https://orcid.org/0009-0002-5692-0386
Meenambiga Setti Sudharsan
Department of Bioengineering, School of Engineering, Vels Institute of Science Technology and Advanced Studies, Chennai-600117, India
https://orcid.org/0000-0002-5445-525X

Corresponding Author(s) : Meenambiga Setti Sudharsan

meenambiga.se@vistas.ac.in

Asian Journal of Chemistry, Vol. 37 No. 10 (2025): Vol 37 Issue 10, 2025

Abstract

This study investigates the neuroprotective potential of flavonoid-rich Tinospora cordifolia extract in targeting α-synuclein using a multidisciplinary approach combining in silico, network pharmacology and antioxidant analyses. Ethanolic extract of T. cordifolia was subjected to GC-MS analysis, identifying 130 phytocompounds. These compounds were screened for drug-likeness and pharmacokinetics using Lipinski’s rule of five and ADMET profiling. Network pharmacology identified hub genes such as SNCA, PARK7 and LRRK2, confirming the relevance of selected targets to Parkinson’s disease. Molecular docking studies were conducted against α-synuclein protein (PDB ID: 3Q27), revealing that N,1-dimethyl-4-piperidinamine, exhibited the highest binding affinity (-7.32 kcal/mol), outperforming the standard drug levodopa (-5.98 kcal/mol). Antioxidant potential of T. cordifolia was assessed using DPPH and FRAP assays. The DPPH assay showed strong radical scavenging activity, with up to 85% inhibition at 500 µg/mL, surpassing the standard quercetin. In contrast, FRAP results indicated lower ferric reducing power (~25%), suggesting selective antioxidant mechanisms. The results demonstrate that T. cordifolia contains bioactive compounds with promising neuroprotective, antioxidant and pharmacological properties that could be leveraged for multi-targeted intervention in Parkinson’s disease. These findings support further investigation and development of T. cordifolia-based therapeutic candidates.

Keywords

Parkinson’s disease Network pharmacology Molecular docking Antioxidant activity
(1)
Pandurangan, J.; Pothiraj, H.; Sudharsan, M. S. In Silico Analysis and Antioxidant Activity of Flavonoids from Tinospora Cordifolia Targeting α-Synuclein of Parkinson’s Disease. ajc 2025, 37, 2578-2588.
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. L.V. Kalia and Anthony E. Lang., The Lancet, 386, 9996 (2015); https://doi.org/10.1016/S0140-6736(14)61393-3
  2. J. Jankovic, J. Neurol. Neurosurg. Psychiatry, 79, 368 (2008); https://doi.org/10.1136/jnnp.2007.131045
  3. R. Cacabelos, Int. J. Mol. Sci., 18, 551 (2017); https://doi.org/10.3390/ijms18030551
  4. N. Ball, W.-P. Teo, S. Chandra and J. Chapman, Front. Neurol., 10, 218 (2019); https://doi.org/10.3389/fneur.2019.00218
  5. D.W. Dickson, Parkinsonism Relat. Disord., 46, S30 (2018); https://doi.org/10.1016/j.parkreldis.2017.07.033
  6. M.T. Hayes, Am. J. Med., 132, 802 (2019); https://doi.org/10.1016/j.amjmed.2019.03.001
  7. C.A. Davie, Br. Med. Bull., 86, 109 (2008); https://doi.org/10.1093/bmb/ldn013
  8. M.M. McGregor and A.B. Nelson, Neuron, 101, 1042 (2019); https://doi.org/10.1016/j.neuron.2019.03.004
  9. W. Han, Y. Liu, Y. Mi, J. Zhao, D. Liu and Q.-B. Tian, Am. J. Med. Genet. B. Neuropsychiatr. Genet., 168, 123 (2015); https://doi.org/10.1002/ajmg.b.32288
  10. J.W. Touchman, A. Dehejia, O. Chiba-Falek, D.E. Cabin, J.R. Schwartz, B.M. Orrison, M.H. Polymeropoulos and R.L. Nussbaum, Genome Res., 11, 78 (2001); https://doi.org/10.1101/gr.165801
  11. S.J. Chung, I.R. König, K. Lohmann, F. Hinrichs, J. Kim, H.-S. Ryu, H.J. Lee, K. Kim, J.H. Lee, K.W. Jung, M.J. Kim, M.-J. Kim, Y.J. Kim, S.-C. Yun, S.-M. Hong, S.-J. Myung and C. Klein, Parkinsonism Relat. Disord., 61, 151 (2019); https://doi.org/10.1016/j.parkreldis.2018.10.028
  12. V. Chen, M. Moncalvo, D. Tringali, L. Tagliafierro, A. Shriskanda, E. Ilich, W. Dong, B. Kantor and O. Chiba-Falek, Hum. Mol. Genet., 29, 3107 (2020); https://doi.org/10.1093/hmg/ddaa183
  13. J.T.T. Zhu, R.C.Y. Choi, G.K.Y. Chu, A.W.H. Cheung, Q.T. Gao, J. Li, Z.Y. Jiang, T.T.X. Dong and K.W.K. Tsim, J. Agric. Food Chem., 55, 2438 (2007); https://doi.org/10.1021/jf063299z
  14. P. Sharma, B.P. Dwivedee, D. Bisht, A.K. Dash and D. Kumar, Heliyon, 5, e02437 (2019); https://doi.org/10.1016/j.heliyon.2019.e02437
  15. D. Singh and P.K. Chaudhuri, Nat. Prod. Commun., 12, 299 (2017); https://doi.org/10.1177/1934578X1701200234
  16. A. Mishra, S. Kumar, A. Bhargava, B. Sharma and A.K. Pandey, Cell. Mol. Biol., 57, 16 (2011).
  17. S. Mathew and G. Kuttan, J. Exp. Clin. Cancer Res., 16, 407 (1997).
  18. R.P. Singh, S. Banerjee, P.V.S. Kumar, K.A. Raveesha and A.R. Rao, Phytomedicine, 13, 74 (2006); https://doi.org/10.1016/j.phymed.2004.02.013
  19. P.S.M. Prince and V.P. Menon, Phytother. Res., 15, 213 (2001); https://doi.org/10.1002/ptr.707
  20. K. Arunachalam, X. Yang and T.T. San, J. Ethnopharmacol., 283, 114540 (2022); https://doi.org/10.1016/j.jep.2021.114540
  21. J. Kosaraju, S. Chinni, P.D. Roy, E. Kannan, A.S. Antony and M.N.S. Kumar, Indian J. Pharmacol., 46, 176 (2014); https://doi.org/10.4103/0253-7613.129312
  22. T. Balasundari and M. Boominathan, World J. Sci. Res., 3, 1 (2018).
  23. D. Gomathi, M. Kalaiselvi, G. Ravikumar, K. Devaki and C. Uma, J. Food Sci. Technol., 52, 1212 (2015); https://doi.org/10.1007/s13197-013-1105-9
  24. A. Sinha, H.P. Sharma, B. Singh and A. Patnaik, World J. Pharm. Res., 6, 1319 (2017).
  25. D. Szklarczyk, A.L. Gable, K.C. Nastou, D. Lyon, R. Kirsch, S. Pyysalo, N.T. Doncheva, M. Legeay, T. Fang, P. Bork, L.J. Jensen and C. von Mering, Nucleic Acids Res., 49, 10800 (2021); https://doi.org/10.1093/nar/gkab835
  26. P. Shannon, A. Markiel, O. Ozier, N. S. Baliga, J. T. Wang, D. Ramage, N. Amin, B. Schwikowski, and T. Ideker, Genome Res., 13, 2498 (2003); https://doi.org/10.1101/gr.1239303
  27. Y. Zheng, Z. Zhong and X. Guo, Anticancer. Agents Med. Chem., 22, 10 (2022); https://doi.org/10.2174/1871520621666211015140455
  28. H.I. Umar, T.P. Saliu, S.S. Josiah, A. Ajayi and J.B. Danjuma, Egypt. J. Med. Hum. Genet., 22, 60 (2021); https://doi.org/10.1186/s43042-021-00175-8
  29. M. Abdul-Hammed, I.O. Adedotun, M. Olajide, C.O. Irabor, T.I. Afolabi, I.O. Gbadebo, L. Rhyman and P. Ramasami, Nat. Prod. Res., 36, 3110 (2022); https://doi.org/10.1080/14786419.2021.1935933
  30. J. Zhang, J. Biomol. Struct. Dyn., 39, 9 (2021); https://doi.org/10.1080/07391102.2020.1713891
  31. S.V. Giofrè, E. Napoli, N. Iraci, A. Speciale, F. Cimino, C. Muscarà, M.S. Molonia, G. Ruberto and A. Saija, Comput. Biol. Med., 134, 104538 (2021); https://doi.org/10.1016/j.compbiomed.2021.104538
  32. S.U. Khan, N. Ahemad, L.-H. Chuah, R. Naidu and T.T. Htar, Progr. Drug Discov. Biomed. Sci., 3, 1 (2020); https://doi.org/10.36877/pddbs.a0000054.
  33. H.A. Odhar, S.W. Ahjel, A.A. Albeer, A.F. Hashim, A.M. Rayshan, and S.S. Humadi, Bioinformation, 16, 236 (2020); https://doi.org/10.6026/97320630016236
  34. U. Baroroh, S. Si., M.Biotek, Z.S. Muscifa, W. Destiarani, F.G. Rohmatullah and M. Yusuf, Indones. J. Comput. Biol., 2, 1 (2023); https://doi.org/10.24198/ijcb.v2i1.46322
  35. V. Katalinic, M. Milos, T. Kulisic and M. Jukic, Food Chem., 94, 500 (2006); https://doi.org/10.1016/j.foodchem.2004.12.004
  36. I.F.F. Benzie and J.J. Strain, Anal. Biochem., 239, 70 (1996); https://doi.org/10.1006/abio.1996.0292
  37. R. Papitha, R. Lokesh, R. Kaviyarasi and C.I. Selvaraj, Int. J. Pharmacogn. Phytochem. Res., 8, 12 (2016).
  38. A. Gupta, P. Gupta and G. Bajpai, Heliyon, 10, e26125 (2024); https://doi.org/10.1016/j.heliyon.2024.e26125
  39. J. Botelho, P. Mascarenhas, J.J. Mendes and V. Machado, Genes, 11, 1385 (2020); https://doi.org/10.3390/genes11111385
  40. Z. Shen, M. Yu and S. Zhang, BioMed Res. Int., 2022, 4758189 (2022); https://doi.org/10.1155/2022/4758189
  41. V. Cappello, L. Marchetti, P. Parlanti, S. Landi, I. Tonazzini, M. Cecchini, V. Piazza and M. Gemmi, Sci. Rep., 6, 1 (2016); https://doi.org/10.1038/s41598-016-0001-8
  42. R. Elango, B. Banaganapalli, A. Mujalli, N. AlRayes, S. Almaghrabi, M. Almansouri, A. Sahly, G.A. Jadkarim, M.Z. Malik, H.I. Kutbi, N.A. Shaik and E. Alefishat, Bioinform. Biol. Insights, 17, 11779322231166214 (2023); https://doi.org/10.1177/11779322231166214
  43. N. Srinath, M. S. Vijayalakshmi, H. Sowmya, and S. Sakthiselvan, Oxid. Commun., 46, 799 (2023).
  44. O.J. Onoja, T.O. Elufioye, Z.A. Sherwani and Z. Ul-Haq, J. Biol. Active Prod. Nature, 10, 100 (2020); https://doi.org/10.1080/22311866.2020.1726813
  45. A. Arya, S. Kumar, D. Kain, V. Vandana and K. Mikawlrawng, J. Herbmed. Pharmacol., 13, 407 (2024); https://doi.org/10.34172/jhp.2024.48085
  46. X. Hei, M. Xie, J. Xu, J. Li and T. Liu, Neurochem. Res., 45, 1953 (2020); https://doi.org/10.1007/s11064-020-03060-9
  47. S.S. Hassan, S. Samanta, R. Dash, T.M. Karpiński, E. Habibi, A. Sadiq, A. Ahmadi and S. Bungau, Front. Pharmacol., 13, 1015835 (2022); https://doi.org/10.3389/fphar.2022.1015835
  48. J. Kosaraju, S. Chinni, P.D. Roy, E. Kannan, A.S. Antony and M.N.S. Kumar, Indian J. Pharmacol., 46, 176 (2014); https://doi.org/10.4103/0253-7613.129312
Read More
Author biographies is not available.
Crossref
Scopus
Google Scholar
Europe PMC
Download
PDF
Statistic
Read Counter : 181 Download : 101
PlumX